Aixcrypto Holdings, INC. (AIXC) SEC Filings — 2025

Filings

• Aixcrypto Holdings, INC. 8-K Filing — 8-K · Dec 16, 2025
• AIxCrypto Sets Virtual 2024 Annual Meeting for Dec 30, Key Votes Ahead — DEF 14A · Dec 15, 2025
• AIxCrypto Pivots to Crypto Treasury, Secures $41M Private Placement — S-1 · Dec 4, 2025
• AIxCrypto Holdings Files 8-K with Financials — 8-K · Nov 21, 2025
• Aixcrypto Holdings, INC. 8-K Filing — 8-K · Nov 20, 2025
• Qualigen Therapeutics Files 8-K with Corporate Updates — 8-K · Nov 17, 2025
• Qualigen's Cash Soars 3200% on $41M Faraday-Backed Private Placement — 10-Q · Nov 14, 2025
• Qualigen Seeks Shareholder Nod for Private Placement, Equity Plan — DEF 14A · Oct 20, 2025
• Qualigen Therapeutics Changes Auditors to BDO USA — 8-K · Oct 7, 2025
• Qualigen Therapeutics Files 8-K with Material Agreements — 8-K · Oct 3, 2025
• Qualigen Therapeutics Files 8-K on Officer/Director Changes — 8-K · Sep 29, 2025
• Qualigen Therapeutics Files 8-K — 8-K · Sep 25, 2025
• Qualigen Therapeutics Files 8-K for Material Agreement — 8-K · Sep 16, 2025
• Qualigen Therapeutics Faces Delisting Notice — 8-K · Sep 8, 2025
• Qualigen Therapeutics Enters Material Definitive Agreement — 8-K · Aug 27, 2025
• AIXC's Net Loss Widens 20% Amid Soaring G&A, Cash Dwindles — 10-Q · Aug 14, 2025
• Qualigen Therapeutics Files 8-K with Key Agreements and Equity Sales — 8-K · Jul 28, 2025
• Qualigen Narrows Q1 Loss to $2.2M Amidst Ongoing Capital Raises — 10-Q · Jul 21, 2025
• Qualigen Therapeutics Files 8-K — 8-K · Jul 16, 2025
• Qualigen Therapeutics Navigates Pre-Revenue Stage with Capital Raises — 10-K · Jun 30, 2025
• Qualigen Therapeutics Announces Board and Executive Changes — 8-K · Jun 24, 2025
• Qualigen Therapeutics Faces Delisting Concerns — 8-K · May 19, 2025
• Qualigen Therapeutics Faces Delisting Concerns — 8-K · May 1, 2025
• Qualigen Therapeutics Files 8-K Report — 8-K · Jan 28, 2025